LigaChem Biosciences Inc. (KOSDAQ:141080)
147,700
+600 (0.41%)
Sep 18, 2025, 3:30 PM KST
LigaChem Biosciences Revenue
LigaChem Biosciences had revenue of 32.62B KRW in the quarter ending June 30, 2025, with 6.06% growth. This brings the company's revenue in the last twelve months to 148.28B, up 94.55% year-over-year. In the year 2024, LigaChem Biosciences had annual revenue of 125.90B with 268.71% growth.
Revenue (ttm)
148.28B
Revenue Growth
+94.55%
P/S Ratio
36.27
Revenue / Employee
872.24M
Employees
170
Market Cap
5,378.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 125.90B | 91.75B | 268.71% |
Dec 31, 2023 | 34.15B | 733.60M | 2.20% |
Dec 31, 2022 | 33.41B | 1.26B | 3.90% |
Dec 31, 2021 | 32.16B | -25.34B | -44.07% |
Dec 31, 2019 | 57.50B | 32.26B | 127.81% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |